• About Allist
    Profile
    Awards & Recognition
    History
  • R & D
    Clinical Trial
    Clinical Study
    Manufacturing
    Collaborations & Partnership
  • Products
    Furmonertinib
  • Career
    Corporate Culture
    Job Opportunity
    Contact us
  • News
  • Investors
    Company Announcements
    Corporate Governance
    Contact Info
English
中文
菜单
  • Home
  • About Allist
    • Profile
    • Awards & Recognition
    • History
    • Management Team
  • R & D
    • Clinical Trial
    • Academic Achievements
    • Manufacturing
    • Collaborations & Partnership
  • Products
    • Furmonertinib
  • Career
    • Corporate Culture
    • Job Opportunity
    • Contact us
  • News
  • Investors
    • Company Announcements
    • Corporate Governance
    • Contact Info
  • 不良事件报告
  • English
  • Advancing Long Life with
    Innovation of Science and Technology

  • An innovative
    biopharmaceutical company

News
  • Furmonertinib Approved for First-Line Treatment
    2022/06/29
  • Furmonertinib Once Again Published in The Lancet Respiratory Medicine
    2022/06/03
  • New Evidence: Furmonertinib First-Line Treatment for CNS Metastases Data Released at the ASCO Annual Meeting
    2022/05/27
  • Accelerated Breakthrough: Allist’s Q3 financial report. Performance overview:
    2021/10/29
  • Allist Chief Chemistry Officer Dr. Luo Huibing: “Precision R&D” with Artistic Elegance
    2021/09/22
  • Dongguan Citizen Insurance Upgraded: Care-free Furmonertinib
    2021/09/02
  • Furmonertinib Entered Wuxi: Inclusive Commercial Insurance List Upgraded
    2021/09/01
  • Lecheng, Boao rolls out global special drug insurance 2021 where Furmonertinib incorporated!
    2021/09/01
  • Allist 2021 Semi-annual Report
    2021/08/24
  • About Allist
    Profile
    Awards &
    Recognition
    History
  • R & D
    Clinical Trial
    Academic
    Achievements
    Manufacturing
    Collaborations &
    Partnership
  • Products
    Furmonertinib
  • Career
    Corporate Culture
    Job Opportunity
    Contact us
  • News
  • Investors
    Company
    Announcements
    Corporate
    Governance
    Contact Info
© 2021 ALLIST All rights reserved 沪ICP备09019898号-2 沪公网安备 31011502004392号 Design: by Eastdays
互联网药品信息服务资格证书编号:(沪)-非经营性-2022-0007 Privacy NoticeCopyright Notice